# Donald Richards

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/donald-richards/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,414 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 54 |
| i10-index | 143 |
| Last Known Institution | Cedars-Sinai Smidt Heart Institute |
| OpenAlex ID | https://openalex.org/A5015961133 |
| ORCID iD | https://orcid.org/0000-0002-2254-4514 |
| Works | 392 |

## Researcher papers

- [Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-versus-sunitinib-in-first-line-treatment-of/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Researcher university

- [Cedars-Sinai Smidt Heart Institute](https://scholariq.org/institutions/cedars-sinai-smidt-heart-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.